Ledger.Open graph →
SEC Form D · filed February 20, 2025

EnZeta Immunotherapies, Inc

Offering
$1.0M
Sold
$200K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CORAL GABLES, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Paul Kelly · Coral Gables, FLExec · DirectorSergio Traversa · Coral Gables, FLDirectorStephen I. Robie · New York, NYExec · DirectorGaurav Lall · STATEN ISLAND, NYExec · DirectorSergio Traversa · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗